[Omalizumab for severe vernal keratoconjunctivitis].

Callet, M

[Omalizumab for severe vernal keratoconjunctivitis]. [electronic resource] - Journal francais d'ophtalmologie Dec 2018 - e499-e500 p. digital

Publication Type: Case Reports; Letter

1773-0597

10.1016/j.jfo.2018.06.001 doi


Anti-Allergic Agents--therapeutic use
Child
Conjunctivitis, Allergic--drug therapy
Drug Resistance--drug effects
Humans
Male
Omalizumab--pharmacology
Severity of Illness Index
Treatment Outcome